Your browser doesn't support javascript.
loading
Current Status of Drug Delivery Approaches and Assay of Anti-Migraine Drugs.
Esim, Ozgur; Savaser, Ayhan; Karadurmus, Leyla; Bakirhan, Nurgul K; Ozkan, Sibel A; Ozkan, Yalcin.
Afiliación
  • Esim O; Department of Pharmaceutical Technology, Gulhane Faculty of Pharmacy, University of Health Sciences, Ankara, Turkey.
  • Savaser A; Department of Pharmaceutical Technology, Gulhane Faculty of Pharmacy, University of Health Sciences, Ankara, Turkey.
  • Karadurmus L; Department of Analytical Chemistry, Faculty of Pharmacy, Adiyaman University, Adiyaman, Turkey.
  • Bakirhan NK; Department of Analytical Chemistry, Gulhane Faculty of Pharmacy, University of Health Sciences, Ankara, Turkey.
  • Ozkan SA; Department of Analytical Chemistry, Faculty of Pharmacy, University of Ankara, Ankara 06100, Turkey.
  • Ozkan Y; Department of Pharmaceutical Technology, Gulhane Faculty of Pharmacy, University of Health Sciences, Ankara, Turkey.
Curr Drug Deliv ; 18(2): 121-146, 2021.
Article en En | MEDLINE | ID: mdl-32384032
Migraine is a chronic, painful, neurological disorder that affects approximately 15% of the population worldwide. It is a form of neurovascular headache: a disorder in which neural events result in the dilation of blood vessels that, in turn, results in pain and further nerve activation. The pathogenesis of migraine is not completely understood, but it is thought that both central and peripheral stimulations can play a role in migraine. Experimental pharmacological evidence suggests that some drugs can have actions in migraine treatment and oral drug delivery is the first choice for these drugs. However, the oral absorption of many drugs is delayed during migraine attacks. Therefore, there may be an advantage to other drug delivery routes, such as parenteral and intranasal. Moreover, nanoparticles can be used for improved drug delivery of anti-migraine agents as they can protect the encapsulated drug from biological and/or chemical degradation, and extracellular transport by P-gp efflux proteins. Various analytical studies have been performed to sensitive and selective assays of antimigraine drugs from commercial and real samples. Anti-migraines, either single or combined with other drugs, can be easily detected by several analytical methods, such as ultraviolet spectrometry, visible spectrometry, high-performance liquid chromatography, liquid chromatography-mass spectrometry, and high-performance thin layer chromatography. This review focuses on the status of antimigraine drug delivery technologies and possible routes for drug delivery. Moreover, it will present their analytical assays with different methods.
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Preparaciones Farmacéuticas / Trastornos Migrañosos Límite: Humans Idioma: En Revista: Curr Drug Deliv Asunto de la revista: FARMACIA / FARMACOLOGIA / TERAPIA POR MEDICAMENTOS Año: 2021 Tipo del documento: Article País de afiliación: Turquía Pais de publicación: Emiratos Árabes Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Preparaciones Farmacéuticas / Trastornos Migrañosos Límite: Humans Idioma: En Revista: Curr Drug Deliv Asunto de la revista: FARMACIA / FARMACOLOGIA / TERAPIA POR MEDICAMENTOS Año: 2021 Tipo del documento: Article País de afiliación: Turquía Pais de publicación: Emiratos Árabes Unidos